Literature DB >> 25896106

Methods of Rotation From Another Strong Opioid to Methadone for the Management of Cancer Pain: A Systematic Review of the Available Evidence.

Sarah McLean1, Feargal Twomey2.   

Abstract

CONTEXT: Up to 44% of patients with cancer-related pain require opioid rotation (OR) because of inadequate analgesia or side effects. No consensus exists regarding the most efficacious method for rotation to methadone.
OBJECTIVES: To define the available evidence regarding methods of rotation to methadone and to determine if sufficient evidence exists regarding the superiority of one method.
METHODS: A predefined search strategy, using Medical Subject Headings (MeSH) search terms and keywords combined using Boolean operators, was performed. Study selection was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance. Data were extracted, quality of studies assessed, and narrative synthesis undertaken.
RESULTS: A total of 3214 potentially relevant studies were identified. Twenty-five studies were included: 15 retrospective and 10 prospective (n = 1229). One trial compared three-day switch (3DS) and rapid conversion (RC) methods; two, 3DS; 10, RC; nine, ad libitum (AL). Success rates were as follows: 3DS-93%, RC-71.7%, and AL-92.8%. The single clinical trial and retrospective studies demonstrated poorer analgesia and an excess of adverse events (AEs) in the RC group (five dropouts because of AEs) compared with the 3DS group (no severe AEs). Time to stable analgesia was as follows: RC <4.3 days and AL <6 days.
CONCLUSION: Evidence identified was mainly from uncontrolled observational studies, making causality difficult to establish. Studies were heterogeneous in methodology and outcome measures. There was a trend toward excess AEs using the RC method, in comparison to the AL and 3DS methods. The methodological quality of the AL studies was low. A direct comparison of AL and 3DS methods would be informative.
Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Methadone; ad libitum; cancer pain; opioid rotation; rapid conversion; review; three-day switch

Mesh:

Substances:

Year:  2015        PMID: 25896106     DOI: 10.1016/j.jpainsymman.2015.02.029

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  9 in total

Review 1.  Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies.

Authors:  Gudrun Kreye; Eva-Katharina Masel; Klaus Hackner; Beate Stich; Friedemann Nauck
Journal:  Wien Med Wochenschr       Date:  2018-02-19

2.  Opioid Rotation in Cancer Pain Treatment.

Authors:  Michael Schuster; Oliver Bayer; Florian Heid; Rita Laufenberg-Feldmann
Journal:  Dtsch Arztebl Int       Date:  2018-03-02       Impact factor: 5.594

Review 3.  Old Drug, New Pain. Roles and Challenges of Methadone Therapy in Pediatric Palliative Care: A Systematic Review.

Authors:  Francesca Benedetti; Silvia Zoletto; Annalisa Salerno; Irene Avagnina; Franca Benini
Journal:  Front Pediatr       Date:  2022-05-27       Impact factor: 3.569

4.  The Adequateness of Methadone for Japanese Terminal Cancer Patients Can Be Determined Earlier than 7 Days: A Preliminary Retrospective Study.

Authors:  Miho Takemura; Kazuyuki Niki; Yoshiaki Okamoto; Yoshinobu Matsuda; Mikiko Ueda; Etsuko Uejima
Journal:  JMA J       Date:  2020-07-07

Review 5.  Treatment of Neuropathic Pain Directly Due to Cancer: An Update.

Authors:  Morena Shkodra; Augusto Caraceni
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

Review 6.  How to Use Methadone in an Era of an Opioid Epidemic.

Authors:  Yvonne Heung; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2020-03-19

7.  Methadone for Analgesia in Children with Life-Limiting Illness: Experience from a Tertiary Children's Health Service.

Authors:  Christine Mott; Amrita Sarpal; Krista Moss; Anthony Herbert
Journal:  Children (Basel)       Date:  2018-06-27

8.  Methadone as a "Tumor Theralgesic" against Cancer.

Authors:  Marta Michalska; Arndt Katzenwadel; Philipp Wolf
Journal:  Front Pharmacol       Date:  2017-10-31       Impact factor: 5.810

9.  Preparation, Characterization and Dermal Delivery of Methadone.

Authors:  Chin-Ping Kung; Bruno C Sil; Jonathan Hadgraft; Majella E Lane; Bhumik Patel; Renée McCulloch
Journal:  Pharmaceutics       Date:  2019-10-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.